Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota. Show More...
-
Website https://www.panbela.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.24 USD
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 2021-12 TTM Earnings Per Share USD 1.7 -1.5 -6.9 -3.5 -1.65 -2.91 -1.27 -1.09 -0.62 -0.87 -0.91 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 3.0 4.0 5.0 6.0 8.0 12.0 13.0 Book Value Per Share * USD -3.97 -0.67 -1.09 -0.55 -0.11 0.36 0.99 1.0 0.49 Free Cash Flow Per Share * USD 0.36 -2.13 -0.8 -1.0 -0.7 -0.38 -0.52 -0.57 Return on Assets % 57.22 -37.09 -22.79 -444.85 -380.78 -443.15 -245.93 -73.6 -89.35 -115.54 Financial Leverage (Average) 7.08 2.27 1.16 1.26 1.68 Return on Equity % -750.15 -96.98 -108.63 -162.99 Return on Invested Capital % -389.91 -96.65 -108.51 -162.84 Interest Coverage 7.85 -4.9 -2.01 -30.05 -29.29 -5.75 -2.4 -2.02 -296.82 -964.73 Current Ratio 0.52 0.65 0.64 1.26 0.16 0.18 1.13 1.76 7.14 4.62 1.76 Quick Ratio 0.52 0.65 0.63 1.21 0.14 0.14 1.07 1.6 6.85 4.58 1.72 Debt/Equity